Sanofi Non Operating Income Net Other from 2010 to 2026
| SNY Stock | USD 46.01 1.02 2.17% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.1 B, Interest Expense of 406.1 M or Selling General Administrative of 11.1 B, as well as many indicators such as Price To Sales Ratio of 3.87, Dividend Yield of 0.0241 or PTB Ratio of 1.34. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.
Sanofi | Non Operating Income Net Other | Build AI portfolio with Sanofi Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.